Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$336M |
| 2 |
Truist Financial
TFC
|
+$144M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$103M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$91.6M |
| 5 |
Home Depot
HD
|
+$90.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$323M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$136M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$56.6M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$41.5M |
| 5 |
VSM
Versum Materials, Inc.
VSM
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.04% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 10.19% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
International Bancshares
IBOC
$4.53B
| $25.2M | 0.01% |
584,756
-22,116
| -4% | -$917K |
|
|
WMGI
1052
DELISTED
Wright Medical Group Inc
WMGI
| $25.2M | 0.01% |
825,179
+18,535
| +2% | +$485K |
|
1053
Dropbox
DBX
$7.52B
| $25.1M | 0.01% |
1,403,779
+35,266
| +3% | +$664K |
|
|
MRTX
1054
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $25.1M | 0.01% |
195,051
+5,280
| +3% | +$509K |
|
1055
CONMED
CNMD
$1.48B
| $25.1M | 0.01% |
224,498
+2,294
| +1% | +$244K |
|
1056
TriNet
TNET
$3.09B
| $25.1M | 0.01% |
443,421
+6,584
| +2% | +$366K |
|
|
SIX
1057
DELISTED
Six Flags Entertainment Corp.
SIX
| $25.1M | 0.01% |
556,262
+15,344
| +3% | +$706K |
|
1058
Innospec
IOSP
$2.29B
| $25.1M | 0.01% |
242,438
+4,050
| +2% | +$387K |
|
|
BCPC
1059
Balchem Corp
BCPC
$5.65B
| $25.1M | 0.01% |
246,591
+15,503
| +7% | +$1.56M |
|
1060
Exelixis
EXEL
$13.1B
| $25M | 0.01% |
1,419,582
-14,411
| -1% | -$244K |
|
1061
Lithia Motors
LAD
$8.35B
| $25M | 0.01% |
170,079
+1,452
| +0.9% | +$218K |
|
1062
Columbia Sportswear
COLM
$2.92B
| $25M | 0.01% |
249,513
+6,271
| +3% | +$595K |
|
|
SAFM
1063
DELISTED
Sanderson Farms Inc
SAFM
| $24.9M | 0.01% |
141,533
+1,131
| +0.8% | +$179K |
|
1064
Carpenter Technology
CRS
$27.8B
| $24.9M | 0.01% |
500,526
+3,215
| +0.6% | +$165K |
|
1065
Itron
ITRI
$4.49B
| $24.9M | 0.01% |
296,802
+2,226
| +0.8% | +$175K |
|
|
IMMU
1066
DELISTED
Immunomedics Inc
IMMU
| $24.9M | 0.01% |
1,174,991
+75,991
| +7% | +$1.34M |
|
1067
NXP Semiconductors
NXPI
$58.9B
| $24.8M | 0.01% |
195,241
-6,073
| -3% | -$705K |
|
1068
Fulton Financial
FULT
$4.6B
| $24.8M | 0.01% |
1,423,305
+7,690
| +0.5% | +$131K |
|
|
BPMC
1069
DELISTED
Blueprint Medicines
BPMC
| $24.8M | 0.01% |
309,471
+5,412
| +2% | +$405K |
|
1070
Chemours
CC
$2.2B
| $24.7M | 0.01% |
1,367,696
+116,537
| +9% | +$1.94M |
|
1071
Under Armour Class C
UA
$2.44B
| $24.7M | 0.01% |
1,288,166
+32,322
| +3% | +$569K |
|
|
MIC
1072
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $24.5M | 0.01% |
572,104
+17,837
| +3% | +$736K |
|
1073
Sanmina
SANM
$10.7B
| $24.5M | 0.01% |
715,476
+69,815
| +11% | +$2.24M |
|
1074
FIVE9
FIVN
$2.58B
| $24.5M | 0.01% |
373,291
+8,780
| +2% | +$537K |
|
1075
H.B. Fuller
FUL
$3.29B
| $24.5M | 0.01% |
474,432
-23,257
| -5% | -$1.15M |
|
Similar funds
Charles Schwab's Q4 2019 Portfolio in Review
As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
- Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
- Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
- Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
- Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
- Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
- Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.
Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.